Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia

被引：17

作者：

Perwein, Thomas ^{[1
]}

Strehl, Sabine ^{[2
]}

Koenig, Margit ^{[2
]}

Lackner, Herwig ^{[1
]}

Panzer-Gruemayer, Renate ^{[2
,3
,4
]}

Mann, Georg ^{[3
,4
]}

Attarbaschi, Andishe

Urban, Ernst-Christian ^{[1
]}

Haas, Oskar A. ^{[2
,3
,4
]}

机构：

[1] Med Univ Graz, Div Pediat Hematol Oncol, Graz, Austria

[2] St Anna Kinderkrebsforsch, CCRI, Vienna, Austria

[3] St Anna Childrens Hosp, Vienna, Austria

[4] Med Univ Vienna, Vienna, Austria

来源：

HAEMATOLOGICA | 2016年 / 101卷 / 08期

关键词：

acute lymphoblastic leukemia; RCSD1-ABL1-positive; relapse; long-term remission; imatinib; PH-LIKE; KINASE; PATIENT; FUSION; ABL1; GENE;

D O I：

10.3324/haematol.2015.139568

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E332 / E335

页数：4

共 15 条

[1] Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia [J].

Collette, Y. ;

Prebet, T. ;

Goubard, A. ;

Adelaide, J. ;

Castellano, R. ;

Carbuccia, N. ;

Garnier, S. ;

Guille, A. ;

Arnoulet, C. ;

Charbonier, A. ;

Mozziconacci, M. J. ;

Birnbaum, D. ;

Chaffanet, M. ;

Vey, N. .

BLOOD CANCER JOURNAL, 2015, 5 :e292-e292

[2] A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia [J].

De Braekeleer, E. ;

Douet-Guilbert, N. ;

Le Bris, M-J ;

Berthou, C. ;

Morel, F. ;

De Braekeleer, M. .

LEUKEMIA, 2007, 21 (10) :2220-2221

[3] Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion [J].

De Braekeleer, E. ;

Douet-Guilbert, N. ;

Guardiola, P. ;

Rowe, D. ;

Mustjoki, S. ;

Zamecnikova, A. ;

Al Bahar, S. ;

Jaramillo, G. ;

Berthou, C. ;

Bown, N. ;

Porkka, K. ;

Ochoa, C. ;

De Braekeleer, M. .

LEUKEMIA, 2013, 27 (06) :1422-1424

[4] ABL1 fusion genes in hematological malignancies: a review [J].

De Braekeleer, Etienne ;

Douet-Guilbert, Nathalie ;

Rowe, David ;

Bown, Nick ;

Morel, Frederic ;

Berthou, Christian ;

Ferec, Claude ;

De Braekeleer, Marc .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (05) :361-371

[5] The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias [J].

Duhoux, Francois P. ;

Auger, Nathalie ;

De Wilde, Sigrid ;

Wittnebel, Sebastian ;

Ameye, Genevieve ;

Bahloula, Khadija ;

Van den Berg, Catherine ;

Libouton, Jeanne-Marie ;

Saussoy, Pascale ;

Grand, Francis H. ;

Demoulin, Jean-Baptiste ;

Poirel, Helene A. .

LEUKEMIA RESEARCH, 2011, 35 (07) :E114-E117

[6] A t(1;9)(q23.3∼q25;q34) affecting the ABL1 gene in a biphenotypic leukemia [J].

García, JRG ;

Bohlander, SK ;

Angulo, MG ;

Flores, MAE ;

Cárdenas, VJP ;

Espinoza, JPM ;

Madrigal, MDA ;

Rivera, H .

CANCER GENETICS AND CYTOGENETICS, 2004, 152 (01) :81-83

[7] Role of ABL family kinases in cancer: from leukaemia to solid tumours [J].

Greuber, Emileigh K. ;

Smith-Pearson, Pameeka ;

Wang, Jun ;

Pendergast, Ann Marie .

NATURE REVIEWS CANCER, 2013, 13 (08) :559-571

[8] Tyrosine Kinase Inhibitor Use in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Anemia [J].

Hunger, Stephen P. .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, :361-365

[9] RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations [J].

Inokuchi, Koiti ;

Wakita, Satoshi ;

Hirakawa, Tsuneaki ;

Tamai, Hayato ;

Yokose, Norio ;

Yamaguchi, Hiroki ;

Dan, Kazuo .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (03) :255-260

[10]

Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI [10.1155/2014/357027, 10.1155/2014/852748]

← 1 2 →